Vaidya Sane Ayurved Laboratories Limited — Important, 06-12-2024: General Updates

The Audit Committee of Vaidya Sane Ayurved Laboratories Limited has resolved the forfeiture of 5,00,000 fully convertible warrants due to the non-exercise of the option to convert them into equity shares within the stipulated eighteen-month period. These warrants, issued at ₹221.35 each on May 27, 2023, included 2,50,000 allotted to the promoter category and 2,50,000 to a promoter group company. The forfeiture results in the company retaining ₹2.76 crore, representing the upfront 25% of the issue price paid by the allottees. This development may have implications for liquidity and shareholder sentiments, necessitating close observation moving forward.